author-photo

Xinshan Kang

8

Papers

191

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy) phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): A topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration

2008 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (35)
Composes et compositions servant a moduler les recepteurs chimiosensoriels et leurs ligands

2008
Show All
- Source
- Cite
- Save
Citations (0)
Targeting Drug Resistant Mutations Using Novel Binding Interactions - Lessons Learned from Abl-T315I and their Implications in D

2007
Show All
- Source
- Cite
- Save
Citations (3)
Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine—a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays

2007 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (39)
Discovery and preliminary structure–activity relationship studies of novel benzotriazine based compounds as Src inhibitors

2006 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (23)